# Biomedical & healthcare

20 application records.

| ID | Application | Boundary | Maturity |
|---|---|---|---|
| BIO-01 | MRI adaptive acquisition and sequence orchestration | Addition to MRI acquisition and control; not a magnet replacement. | Near-term research pilot |
| BIO-02 | MRI physics-constrained direct parameter query | Partial replacement of selected reconstruction stages for bounded tasks. | Research prototype |
| BIO-03 | MRI narrow diagnostic instrument as an alternative to full imaging | Alternative narrow instrument; full MRI replacement unsupported. | Frontier concept |
| BIO-04 | MRI motion, respiratory and cardiac event gating | Addition. | Near-term pilot |
| BIO-05 | MRI safety and implant compatibility engine | Addition to safety workflow. | Implementable integration |
| BIO-06 | Ultrasound echo-event acquisition and beam control | Addition or partial replacement of acquisition/reconstruction for narrow tasks. | Research prototype |
| BIO-07 | CT/PET task-specific sparse acquisition | Addition/partial replacement in bounded tasks. | Research concept |
| BIO-08 | Microscopy and cell-culture event microscope | Addition and, for narrow assays, partial replacement of continuous imaging. | Near-term research pilot |
| BIO-09 | ICU and ward event-native patient monitoring | Addition to monitoring and clinical decision support. | Near-term pilot |
| BIO-10 | Surgical navigation and tool-tissue time-of-contact | Addition. | Research prototype |
| BIO-11 | Medication, infusion and closed-loop therapy guard engine | Addition. | Near-term pilot |
| BIO-12 | Cradle-to-life longitudinal patient journey substrate | Addition beneath EHRs; not an autonomous medical authority. | Implementable architecture pilot |
| BIO-13 | Maternal, fetal, birth and neonatal journey coordination | Addition. | Near-term information-system pilot |
| BIO-14 | Hospital flow, beds, theatres and discharge event twin | Addition/partial replacement of dashboard-centric coordination. | Near-term pilot |
| BIO-15 | Mental-health longitudinal care and research substrate | Addition to records and research; not automated diagnosis or therapy. | Research and governance pilot |
| BIO-16 | Clinical trial and observational study event graph | Addition/partial replacement of document-centric trial operations. | Implementable pilot |
| BIO-17 | Biomedical sample and biobank lineage | Addition. | Implementable integration |
| BIO-18 | Protein dynamics and molecular-event simulation | Hybrid addition; broad replacement unsupported. | Research prototype |
| BIO-19 | CRISPR and gene-editing in-silico candidate pruning | Addition to design; not physical gene control. | Research concept |
| BIO-20 | Public-health event and service-absence observatory | Addition. | Near-term data pilot |

## Application notes

### BIO-01 - MRI adaptive acquisition and sequence orchestration

Use local anatomical/physiological support, motion and safety compatibility, and quantitative guard conditions to adapt which measurements are acquired next.

**Current baseline:** Fixed or protocol-driven pulse sequences acquire k-space data and reconstruct images before downstream interpretation.

**Event guard:** Acquire the next encoding block when predicted information gain or quantitative uncertainty crosses a declared threshold and safety constraints remain satisfied.

**Auditable absence:** Expected calibration, physiological gating or coil data fail to arrive within the sequence window despite verified sensor coverage.

**Pilot:** Retrospective raw-data replay, then a phantom or volunteer study with a locked protocol and conventional reconstruction reference.

**Metrics:** Diagnostic task performance; scan time; acquired samples; SAR and gradient limits; motion artifacts; events/J; false-adaptation rate.

**Risks:** Adaptive bias; missed pathology; instability; regulatory validation; patient safety.

**References:** C0; R1; R2; R3; R5

### BIO-02 - MRI physics-constrained direct parameter query

Represent Bloch-model-compatible signal families as relations and query selected parameters or change events directly, optionally using images as a view.

**Current baseline:** Conventional pipelines produce images, then estimate tissue or functional parameters.

**Event guard:** Parameter posterior or certified interval enters a clinically meaningful range under sufficient acquisition support.

**Auditable absence:** A parameter cannot be certified because the required excitation/encoding support was never observed.

**Pilot:** Phantom study comparing direct parameter estimates, MRF-style matching and standard image-first workflow.

**Metrics:** Parameter bias/variance; calibration; scan time; task AUC; reconstruction energy; uncertainty coverage.

**Risks:** Model mismatch; dictionary/expression growth; non-identifiability; clinical interpretability.

**References:** C0; R3; R4

### BIO-03 - MRI narrow diagnostic instrument as an alternative to full imaging

Design a task-specific MR instrument that answers a bounded question such as relaxation change, flow threshold or lesion-presence probability without requiring a full diagnostic image.

**Current baseline:** Full MRI forms general-purpose images even when the clinical question is narrow.

**Event guard:** A task-specific signal relation crosses a validated threshold with confidence and safety conditions satisfied.

**Auditable absence:** The expected signal support is absent, but only after coil, sequence and coverage integrity are verified.

**Pilot:** Start with a benchtop NMR/MR phantom and a single quantitative task.

**Metrics:** Sensitivity/specificity; acquisition time; energy; footprint; cost; inconclusive rate; referral-to-full-MRI rate.

**Risks:** Loss of generality; hidden confounders; regulatory burden; false reassurance.

**References:** C0; R1; R4; R5

### BIO-04 - MRI motion, respiratory and cardiac event gating

Treat motion/physiology as continuous state and solve for compatible acquisition windows or correction events rather than replaying uniform frames.

**Current baseline:** Motion correction often relies on repeated acquisition, navigators or retrospective processing.

**Event guard:** Predicted motion enters an admissible window and a sequence block is admitted; otherwise hold or redirect.

**Auditable absence:** A required quiet-window event never occurs within the allowed interval.

**Pilot:** Integrate an external motion sensor with retrospective MR sequence logs.

**Metrics:** Rejected acquisitions; reacquisition rate; image/parameter quality; latency; patient time.

**Risks:** Sensor drift; phase mismatch; prolonged scans; selection bias.

**References:** C0; R1; R3

### BIO-05 - MRI safety and implant compatibility engine

Model implant identity, field strength, sequence limits and patient state as a compatibility predicate with provenance and explicit reason codes.

**Current baseline:** Safety screening is document- and workflow-heavy and can fail when implant identity or conditions are incomplete.

**Event guard:** Scan becomes admissible only when all required device attributes and MR-conditional constraints are present and current.

**Auditable absence:** Missing implant identity or condition is logged as a blocking absence, not silently treated as safe.

**Pilot:** FHIR-compatible registry and rules engine in one MRI service line.

**Metrics:** Screening completeness; prevented unsafe scans; delay time; override rate; auditability.

**Risks:** Incorrect device metadata; stale labeling; workflow bypass; privacy.

**References:** C0; R5; R6

### BIO-06 - Ultrasound echo-event acquisition and beam control

Use level-crossing or feature-triggered acquisition, local beam support and direct arrival-time/flow events to reduce irrelevant conversion and processing.

**Current baseline:** Uniform RF sampling and image formation precede measurement of most clinical features.

**Event guard:** Echo arrival, Doppler shift or tissue-boundary relation crosses a validated threshold within the beam support.

**Auditable absence:** Expected echo absent only when transducer contact and acoustic coverage are verified.

**Pilot:** Phantom and flow-loop test with simultaneous conventional RF capture.

**Metrics:** Samples/event; energy; latency; sensitivity; localization error; image equivalence when a view is produced.

**Risks:** Information loss; nonlinear propagation; aliasing; difficult certification.

**References:** C0; R31

### BIO-07 - CT/PET task-specific sparse acquisition

Select measurement supports adaptively and solve for bounded findings or quantitative changes with explicit uncertainty, retaining full reconstruction as fallback.

**Current baseline:** Tomographic systems acquire projections and reconstruct volumetric images before many decisions.

**Event guard:** Task confidence reaches a preset boundary without violating dose/count constraints.

**Auditable absence:** A required angular or count support is absent; result remains inconclusive rather than negative.

**Pilot:** Digital phantom and archived raw-data challenge.

**Metrics:** Dose or tracer counts; task performance; scan time; uncertainty; fallback rate.

**Risks:** Dose-selection bias; hallucinated structure; regulatory validation.

**References:** C0

### BIO-08 - Microscopy and cell-culture event microscope

Use local optical supports, event sensors or analog prefilters to emit only lineage-aware cell events such as division, migration, morphology change or fluorescence threshold crossing.

**Current baseline:** High-throughput microscopy generates large image stacks that are later searched for rare events.

**Event guard:** A tracked cell lineage crosses a morphology, intensity or interaction guard with sufficient optical support.

**Auditable absence:** Expected cell or marker observation absent only when field coverage and sensor health are known.

**Pilot:** Parallel conventional imaging and event extraction on a well-defined assay.

**Metrics:** Events/J; bytes/experiment; missed/false events; lineage accuracy; phototoxic exposure.

**Risks:** Rare-event miss; lineage swaps; optical drift; loss of serendipitous observations.

**References:** C0; R30

### BIO-09 - ICU and ward event-native patient monitoring

Maintain a continuous patient state, local physiological supports, compatibility with interventions and an auditable event record for threshold crossings and trends.

**Current baseline:** Continuous monitors produce dense streams and alarm fatigue while context is split across systems.

**Event guard:** A validated physiological relation crosses a severity guard and matches the patient context, sensor quality and treatment phase.

**Auditable absence:** Expected vital, medication response or reassessment is absent despite confirmed observation coverage.

**Pilot:** Silent-mode retrospective validation followed by prospective shadow deployment.

**Metrics:** Alarm precision/recall; time to recognition; clinician workload; missed-data rate; intervention outcomes.

**Risks:** Alarm overreach; sensor artifacts; automation bias; privacy; clinical liability.

**References:** C0; R6; R7; R8; R10

### BIO-10 - Surgical navigation and tool-tissue time-of-contact

Represent tool and anatomy trajectories continuously; solve certified time-of-contact events within local support and surgical permissions.

**Current baseline:** Navigation and collision checks often run at fixed update rates and depend on reconstructed scenes.

**Event guard:** Earliest predicted tool/tissue contact or no-go-zone crossing under uncertainty.

**Auditable absence:** Tracking signal absence blocks the action rather than implying clearance.

**Pilot:** Simulation and benchtop phantom with a conventional navigation baseline.

**Metrics:** Contact-time error; missed crossings; latency; false stops; surgeon workload.

**Risks:** Deformable anatomy; tracking dropout; model error; safety certification.

**References:** C0; R33; R34

### BIO-11 - Medication, infusion and closed-loop therapy guard engine

Join medication identity, dose lineage, patient state, timing and device status through compatibility and event guards; keep clinicians in the loop.

**Current baseline:** Orders, pump state, labs and observations are often stored in separate snapshots.

**Event guard:** Dose or infusion transition is admitted only when patient, order, pump, drug, route and timing are compatible.

**Auditable absence:** Expected reassessment, pump acknowledgment or lab result is missing after its due interval.

**Pilot:** One high-risk infusion pathway in simulation and shadow mode.

**Metrics:** Medication errors; delayed doses; false blocks; response-monitoring completeness; audit time.

**Risks:** Rule brittleness; alert fatigue; override handling; governance.

**References:** C0; R6; R7; R8

### BIO-12 - Cradle-to-life longitudinal patient journey substrate

Use a stable person lineage with prenatal, birth, neonatal, childhood, adult and elder branches; represent encounters and documents as views over a consent- and provenance-aware event graph.

**Current baseline:** Hospital records are encounter- and document-centric; identity and context fragment across organizations and life stages.

**Event guard:** Care transitions, referrals, procedures, consent changes and outcomes are typed events tied to the person lineage.

**Auditable absence:** Expected follow-up, screening, handoff, result or support service is absent only under an explicit obligation and coverage rule.

**Pilot:** One maternal-neonatal or chronic-care pathway across two organizations using FHIR events and PROV lineage.

**Metrics:** Record-linkage errors; care-gap closure; duplicate testing; handoff failures; patient access; consent compliance.

**Risks:** Identity matching; privacy; institutional power; data quality; patient autonomy.

**References:** C0; R6; R7; R8; R28

### BIO-13 - Maternal, fetal, birth and neonatal journey coordination

Model mother, fetus/newborn, samples, devices and care teams as related but distinct lineages, with consent and event transitions at birth.

**Current baseline:** Prenatal, delivery, neonatal and maternal records often sit in separate episodes and systems.

**Event guard:** Birth, transfer, screening, feeding, medication and follow-up transitions preserve parent/child lineage and provenance.

**Auditable absence:** Expected screening or post-discharge follow-up is absent with verified obligation and outreach coverage.

**Pilot:** Neonatal screening and follow-up pathway.

**Metrics:** Missed screens; duplicate identity; handoff delay; maternal/newborn linkage accuracy.

**Risks:** Identity errors; consent complexity; sensitive data exposure.

**References:** C0; R6; R8

### BIO-14 - Hospital flow, beds, theatres and discharge event twin

Represent patient flow, rooms, staff, equipment and constraints as a compatibility-gated event system with next-event and counterfactual queries.

**Current baseline:** Hospitals use dashboards and periodic snapshots that can obscure pending transitions and missing actions.

**Event guard:** A transfer or discharge becomes admissible when clinical, staffing, bed, transport and documentation conditions are satisfied.

**Auditable absence:** Required consult, result, transport or discharge action has not occurred by the due interval.

**Pilot:** One ward-to-discharge process in shadow mode.

**Metrics:** Length of stay; boarding time; cancelled procedures; idle beds; false-ready rate; staff burden.

**Risks:** Optimization against patient welfare; unstable priorities; data latency.

**References:** C0; R6; R7; R10

### BIO-15 - Mental-health longitudinal care and research substrate

Maintain patient-authored goals, consent, context, development, environment, observations and interventions as lineage-aware events and dimensional trajectories.

**Current baseline:** Care is often reduced to episodic diagnoses and self-report snapshots.

**Event guard:** A care or research transition is admitted under explicit consent, role, time and safety predicates, with human review.

**Auditable absence:** Expected check-in or follow-up may be logged as absent, but lack of digital activity is never equated with deterioration without corroboration.

**Pilot:** Patient-controlled longitudinal research registry with independent ethics review.

**Metrics:** Continuity; patient control; follow-up completion; bias; clinician burden; data access.

**Risks:** Surveillance; stigma; coercion; false inference; crisis responsibility.

**References:** C0; R8; R9; R10; R11

### BIO-16 - Clinical trial and observational study event graph

Create a versioned event and provenance graph connecting protocol, consent, intervention, measurement, deviation, analysis and publication.

**Current baseline:** Trials rely on document bundles, site databases and retrospective reconciliation.

**Event guard:** Every trial action creates a typed event with protocol version, authority, subject, time and before/after state.

**Auditable absence:** Expected visit, sample, outcome or adverse-event assessment is explicitly expired, waived or observed.

**Pilot:** Single-site prospective study with export to standard regulatory documents.

**Metrics:** Protocol deviations; reconciliation time; missing data; audit readiness; reproducibility.

**Risks:** Operational complexity; privacy; legal admissibility; version drift.

**References:** C0; R6; R28; R29

### BIO-17 - Biomedical sample and biobank lineage

Use lineage addresses and split/merge rules for specimen, aliquot, derivative, assay and storage events.

**Current baseline:** Samples are split, pooled, transformed and shipped across systems.

**Event guard:** A sample transition is admitted only when identity, consent, chain of custody, storage and assay compatibility are satisfied.

**Auditable absence:** Expected receipt, temperature record or assay result is missing after verified custody.

**Pilot:** One biobank workflow with barcode/EPCIS and PROV mapping.

**Metrics:** Misidentification; unusable samples; audit time; consent violations; freezer excursions.

**Risks:** Legacy identifiers; merge ambiguity; privacy; operational adoption.

**References:** C0; R26; R27; R28

### BIO-18 - Protein dynamics and molecular-event simulation

For selected relation families, solve binding, contact, conformational and threshold events directly, while retaining conventional simulation for unresolved regions.

**Current baseline:** Molecular dynamics often advances short timesteps and stores frames; structure repositories emphasize snapshots.

**Event guard:** Earliest compatible contact, barrier crossing or conformational transition within a bounded model.

**Auditable absence:** A predicted event is absent only when the modeled support and force field are valid; otherwise unknown.

**Pilot:** Small molecule or coarse-grained benchmark against MD trajectories.

**Metrics:** Event-time error; energy conservation; missed states; compute/J; expression growth.

**Risks:** Chaotic dynamics; model inadequacy; event explosion; no general closed form.

**References:** C0

### BIO-19 - CRISPR and gene-editing in-silico candidate pruning

Use local genomic/epigenetic support, compatibility predicates and lineage to rank candidate interventions and downstream event risks before laboratory testing.

**Current baseline:** Guide design uses sequence search, predictive models and experimental validation.

**Event guard:** Candidate passes sequence, structure, cell-context, off-target and policy guards with uncertainty.

**Auditable absence:** Missing cell-context evidence is a blocking absence, not proof of safety.

**Pilot:** Benchmark on public datasets; no clinical use.

**Metrics:** Off-target ranking; experimental hit rate; uncertainty calibration; provenance.

**Risks:** Overconfidence; incomplete biology; dual use; ethical concerns.

**References:** C0; R8; R9

### BIO-20 - Public-health event and service-absence observatory

Use event notifications, local geographic supports, lineage and explicit expected-report contracts to distinguish true absence, delayed data and sensor failure.

**Current baseline:** Public-health systems aggregate delayed reports and dashboards.

**Event guard:** Case, lab, wastewater, capacity or intervention events cross a public-health guard.

**Auditable absence:** Expected report absent only after source coverage, reporting obligation and deadline are verified.

**Pilot:** One syndromic or wastewater surveillance program with transparent absence rules.

**Metrics:** Reporting delay; missingness classification; false alarms; privacy; action time.

**Risks:** Re-identification; political misuse; reporting bias; jurisdiction conflicts.

**References:** C0; R6; R7; R8; R24
